Heterologous Immunity

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Heterologous Immunity trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 4

NCT04899765

Measles and BCG Vaccines for Mother and Child

In Africa, the mortality from infectious diseases remains high. The investigators have discovered that live vaccines such as the BCG vaccine against tuberculosi…

Guinea-Bissau2,400 participantsStarted 2021-05-20

Treatment: BCG vaccine, Measles vaccine

All recent trials (45 shown)

CompletedPhase 4

NCT04445428

OPV as Potential Protection Against COVID-19

Since the 1960s, studies have shown that oral polio vaccine (OPV) may have beneficial non-specific effects, reducing morbidity and mortality from other infectio…

Guinea-Bissau3,729 participantsStarted 2020-07-15

Treatment: oral polio vaccine + information, Information

CompletedPhase 2

NCT07408297

Evaluating Safety and Immune Response of Janssen, Moderna, Pfizer/BNT, and Novavax COVID-19 Vaccines for Same and Mixed…

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus that emerged in the human population in Wuhan City, Hubei Province, China in…

Kenya1,919 participantsStarted 2022-05-18

Treatment: Janssen Ad26COVS1, Pfizer-BioNTech vaccine COVID-19 vaccine

Heterologous Immunity

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Measles and BCG Vaccines for Mother and Child

All recent trials (45 shown)

OPV as Potential Protection Against COVID-19

Evaluating Safety and Immune Response of Janssen, Moderna, Pfizer/BNT, and Novavax COVID-19 Vaccines for Same and Mixed…

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Measles and BCG Vaccines for Mother and Child

All recent trials (45 shown)

OPV as Potential Protection Against COVID-19

Evaluating Safety and Immune Response of Janssen, Moderna, Pfizer/BNT, and Novavax COVID-19 Vaccines for Same and Mixed…

Can BCG Vaccination at First Health-facility Contact Reduce Early Infant Mortality?

Janssen Ad26.CoV2.S Vaccine Booster in Kidney Transplant Recipients

Study to Evaluate the Immune Response After Booster Vaccination With Tdap-IPV Vaccine (Against Tetanus, Diphtheria, Pert…

Measles Vaccination at Health System Contacts

BCG Revaccination With the Third Dose of Diphtheria-tetanus-pertussis Vaccine and Infant Mortality in Africa

Efficacy of Different COVID-19 Vaccine Combinations in Inducing Long-term Humoral Immunity [PRIBIVAC]

Non-specific Effects of FLU-MMR Vaccines in Adults

Vaccine Campaign Effects on General Hospital Admissions and Mortality Among Children

Using BCG to Protect Senior Citizens During the COVID-19 Pandemic

Trial to Compare BCG-Bulgaria and BCG-Denmark

Trained and Heterologous Induced-immune Responses to Tropical Infectious Diseases

Investigating COVID-19 Vaccine Immunity in Children in the Melbourne Infant Study of BCG for Allergy and Infection Reduc…

Efficacy and Safety of Heterologous and Homologous COVID-19 Vaccination

A Study to Evaluate the Ability of UB-612 COVID-19 Vaccine to Boost Immunity of Heterologous COVID-19 Vaccines.

The Immune Response of Heterologous Boost Third Dose of mRNA and Protein COVID-19 Vaccine

Non-specific Effects of BCG in Under-five Children

Evaluating the Safety and Immune Response to Two HIV Vaccine Regimens in Healthy, HIV-Uninfected Adults in the United St…

Safety and Immune Response to Preventive HIV Immunization With Adenovirus Serotype 5 or 35 Vector